Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
6
IVA Quote, Financials, Valuation and Earnings
Last price:
$2.21
Seasonality move
:
-0.27%
Day range:
$2.20 - $2.25
52-week range:
$1.53 - $4.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.58x
P/B ratio:
--
Volume:
15K
Avg. volume:
11.3K
1-year change:
-51.33%
Market cap:
$115.2M
Revenue:
$18.9M
EPS (TTM):
-$2.22
Analysts' Opinion
-
Consensus RatingInventiva SA has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Inventiva SA has an estimated upside of 465.18% from its current price of $2.20.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $2.20.
Fair Value
-
According to the consensus of 0 analysts, Inventiva SA has 465.18% upside to fair value with a price target of -- per share.
IVA vs. S&P 500
-
Over the past 5 trading days, Inventiva SA has underperformed the S&P 500 by -6.27% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Inventiva SA does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Inventiva SA has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Inventiva SA reported revenues of --.
Earnings Growth
-
Inventiva SA has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Inventiva SA reported earnings per share of --.
Enterprise value:
154.5M
EV / Invested capital:
--
Price / LTM sales:
6.58x
EV / EBIT:
--
EV / Revenue:
9.19x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
-1.68x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-171.62%
Net Income Margin (TTM):
-667.09%
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2020-06-30 | 2021-06-30 | |
| Income Statement | ||||||
| Revenue | $3.5M | $6.5M | $345K | $81.5K | $78.3K | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$38.4M | -- | -- | -$9.8M | -$16.5M | |
| EBITDA | -$41.5M | -- | -- | -$9.4M | -$16.9M | |
| Diluted EPS | -$1.90 | -- | -- | -$0.25 | -$0.45 | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $67.7M | $130.7M | $104.4M | $56.9M | $30.7M | |
| Total Assets | $77.3M | $139.5M | $113.2M | $77M | $42.3M | |
| Current Liabilities | $28.3M | $17.7M | $25.1M | $41.1M | $51.6M | |
| Total Liabilities | $30.4M | $34.1M | $40.4M | $85.3M | $127M | |
| Total Equity | $46.9M | $105.3M | $72.8M | -$8.3M | -$84.7M | |
| Total Debt | -- | -- | $16M | $32.8M | $50.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2020-06-30 | 2021-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$42.6M | -$18.7M | -$31.8M | -$3.9M | -$14.5M | |
| Cash From Investing | -$1.3M | -- | -- | -$1.1M | -$2M | |
| Cash From Financing | -$215.8K | -- | -- | $11M | $56.6K | |
| Free Cash Flow | -$43.1M | -- | -- | -- | -- | |
IVA
Sector
Market Cap
$115.2M
$46.1M
Price % of 52-Week High
46.32%
46.02%
Dividend Yield
0%
0%
Shareholder Yield
-23.15%
-0.6%
1-Year Price Total Return
-51.33%
-30.52%
Beta (5-Year)
--
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$2.32
200-day SMA
Sell
Level
$2.82
Bollinger Bands (100)
Sell
Level
2.07 - 2.67
Chaikin Money Flow
Sell
Level
-5.9M
20-day SMA
Sell
Level
$2.49
Relative Strength Index (RSI14)
Sell
Level
29.34
ADX Line
Sell
Level
8.36
Williams %R
Buy
Level
-90.8773
50-day SMA
Sell
Level
$2.61
MACD (12, 26)
Sell
Level
-0.10
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Neutral
Level
23M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-5.6147)
Sell
CA Score
(Annual)
Level (-7.4568)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (12.0632)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
Stock Forecast FAQ
In the current month, IVA has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IVA average analyst price target in the past 3 months is --.
-
Where Will Inventiva SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Inventiva SA share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Inventiva SA?
Analysts are divided on their view about Inventiva SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Inventiva SA is a Sell and believe this share price will drop from its current level to --.
-
What Is Inventiva SA's Price Target?
The price target for Inventiva SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is IVA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Inventiva SA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of IVA?
You can purchase shares of Inventiva SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Inventiva SA shares.
-
What Is The Inventiva SA Share Price Today?
Inventiva SA was last trading at $2.21 per share. This represents the most recent stock quote for Inventiva SA. Yesterday, Inventiva SA closed at $2.20 per share.
-
How To Buy Inventiva SA Stock Online?
In order to purchase Inventiva SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
